Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy. [PDF]
Setti M +15 more
europepmc +1 more source
Evaluation of Tideglusib as a Disease Modifying Therapy in Murine Models of Arrhythmogenic Cardiomyopathy. [PDF]
Malhotra N +16 more
europepmc +1 more source
Comprehensive analysis of desmosomal protein remodelling identifies desmocollin-2 as potential biomarker for arrhythmogenic cardiomyopathy. [PDF]
Ren J +12 more
europepmc +1 more source
Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits. [PDF]
Dei LL +7 more
europepmc +1 more source
Transmembrane Protein 43: Molecular and Pathogenetic Implications in Arrhythmogenic Cardiomyopathy and Various Other Diseases. [PDF]
Orgil BO +7 more
europepmc +1 more source
A zebrafish stable model of Galectin-3 to elucidate its role in Arrhythmogenic Cardiomyopathy
Pilichou K +14 more
europepmc +1 more source
Epigenetic Drugs Splitomicin, Suberohydroxamic Acid, CPTH6, BVT-948, and PBIT Moderate Fibro-Fatty Development in Arrhythmogenic Cardiomyopathy. [PDF]
Lippi M +7 more
europepmc +1 more source
Modelling arrhythmogenic cardiomyopathy fattyfibro pathology with PKP2-deficient epicardial cells derived from human iPSCs. [PDF]
Falana SL +14 more
europepmc +1 more source
Paddling through palpitations: when genes, myocardial inflammation and exercise collide-a case report of arrhythmogenic cardiomyopathy in a young competitive rower. [PDF]
Delpire B +4 more
europepmc +1 more source
Unmet health-related needs of heritable arrhythmogenic cardiomyopathy carriers in Belgium: The UR-HEART survey study. [PDF]
Locquet P +6 more
europepmc +1 more source

